Read more about Artificial intelligence could change future of antimicrobial drug discovery: Here's why on Devdiscourse ...

Advancing proprietary AI discovery of high-bioavailability Oral GLP-1 drug candidates. HOUSTON, Feb. 3, 2026 /PRNewswire/ -- Deep EigenMatics, Inc., a pioneer in high-velocity Artificial Intelligence ...

Overview AI is speeding up drug discovery by analyzing large biological and chemical data in a short time.Deep learning and AI systems help design new drug mole ...

Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.

In the pursuit of solutions to complex global challenges including disease, energy demands, and climate change, scientific ...

Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and decision-making in precision medicine.

Discover how researchers are overcoming the limitations of the undruggable target in drug discovery using novel approaches ...

The global artificial intelligence (AI) in drug discovery market is experiencing rapid expansion, driven by the need to reduce the high costs and long timelines of traditional pharmaceutical ...

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...

The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...

The two partners launch “Bianca”, the first large-scale digitalisation initiative in Italy focused on histopathological samples, aimed at training AI algorithms to support pathologists’ diagnostic ...